# FDA Inspection 966841 - Sharp Corporation - April 20, 2016

Source: https://www.keypedia.com/records/fda_inspections/sharp-corporation/c88a0ba9-0a02-498e-8078-a0bed383c9e4
Source feed: FDA_Inspections

> FDA Inspection 966841 for Sharp Corporation on April 20, 2016. Classification: No Action Indicated (NAI).

---

## Details

- Record Type: FDA Inspection
- Inspection ID: 966841
- Company Name: Sharp Corporation
- Inspection Date: 2016-04-20
- Classification: No Action Indicated (NAI)
- Project Area: Drug Quality Assurance
- Product Type: Drugs
- Office Name: Center for Drug Evaluation and Research

## Related Documents

- [FDA Inspection 763070 - 2012-01-12](https://www.keypedia.com/records/fda_inspections/sharp-corporation/bf35ac9e-a526-4a88-bc96-20ff6cd59a62)
- [FDA Inspection 763070 - 2012-01-12](https://www.keypedia.com/records/fda_inspections/sharp-corporation/8eb6e97b-d3c0-4856-b2d5-74de352e084c)
- [FDA Inspection 681203 - 2010-09-15](https://www.keypedia.com/records/fda_inspections/sharp-corporation/f45bf4d2-560a-4acf-acb3-e8e8607e5ba4)

Company: https://www.keypedia.com/companies/sharp-corporation/2a9a22f8-a6c5-4e1e-9aa9-1e787a229b38

Office: https://www.keypedia.com/offices/center-for-drug-evaluation-and-research/cd980d74-1cbf-4226-ba9a-9045324c236c